Artemisinin Combination Therapies (ACTs) efficacy for uncomplicated falciparum malaria treatment in Burkina Faso

Not Applicable

Completed

• Conditions: Malaria; Infections and Infestations; Plasmodium falciparum malaria

• Registration Number: ISRCTN90823663
• Lead Sponsor: ational Malaria Control Program (Burkina Faso)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-30
• Last Update Posted: 22 May 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 780

Inclusion Criteria

1. Age > 6 months
2. Weight > 5 kg
3. Fever (> 37.5ºC axillary) or history of fever in the previous 24 hours
4. Absence of any history of serious side effects to study medications
5. No evidence of a concomitant febrile illness
6. Provision of informed consent and agreement to follow-up for 28 days
7. No evidence of severe malaria or danger signs
8. Absence of repeated vomiting of study medications on day 0
9. P. falciparum mono-infection
10. Parasite density > 2000/ul and < 200,000/ul

Exclusion Criteria

1. Severe malaria
2. Unable to respect the follow-up schedule
3. Known allergy to the study medication
4. Other chronic disease requiring care

Study & Design

• Study Type: Interventional
• Study Design: Not specified